ID
22408
Beschrijving
Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IV; ODM derived from: https://clinicaltrials.gov/show/NCT00614965
Link
https://clinicaltrials.gov/show/NCT00614965
Trefwoorden
Versies (1)
- 02-06-17 02-06-17 -
Geüploaded op
2 juni 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Non Small Cell Lung Cancer NCT00614965
Eligibility Non Small Cell Lung Cancer NCT00614965
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
mental disorder, social situation, compliance
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0004936
- UMLS CUI [1,2]
- C0748872
- UMLS CUI [1,3]
- C1321605
- UMLS CUI [1,4]
- C0525058
Beschrijving
concurrent uncontrolled illness
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C0205318
Beschrijving
prior malignancy, nonmelanoma skin cancer
Datatype
boolean
Alias
- UMLS CUI [1]
- C2735088
- UMLS CUI [2]
- C3281209
Similar models
Eligibility Non Small Cell Lung Cancer NCT00614965
- StudyEvent: Eligibility
C1708063 (UMLS CUI [1,2])
C0796493 (UMLS CUI [1,3])
C0032181 (UMLS CUI [2])
C0518015 (UMLS CUI [3])
C0373595 (UMLS CUI [2])
C0428772 (UMLS CUI [3])
C0748872 (UMLS CUI [1,2])
C1321605 (UMLS CUI [1,3])
C0525058 (UMLS CUI [1,4])
C0205318 (UMLS CUI [1,2])
C3281209 (UMLS CUI [2])
Geen commentaren